• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Health Products Association - China Executive Director Reflects on Market Dynamics, Challenges

    Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention

    New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance

    Tapping Functional Beverages to Meet Modern Wellness Needs

    Adaptogens: Where Ancient Remedies Meet Modern Wellness Products
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    CRN Announces New Staff Appointments

    Food Supplements Europe: Most Consumers Use Dietary Supplements Safely

    True Westfjords Launches Dropi Cod Liver Oil Tonic

    Alkemist Labs Warns About Missing Components to Pesticide Testing

    Boswellia and Bengal Quince Fruit Extract Blend Linked to Respiratory Benefits
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    True Westfjords Launches Dropi Cod Liver Oil Tonic

    Alkemist Labs Warns About Missing Components to Pesticide Testing

    Boswellia and Bengal Quince Fruit Extract Blend Linked to Respiratory Benefits

    Largest Cannabinoids Trial to Date Yields Positive Findings on Pain Management

    Kensing Acquires Vitae Naturals
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    CRN Announces New Staff Appointments

    Food Supplements Europe: Most Consumers Use Dietary Supplements Safely

    True Westfjords Launches Dropi Cod Liver Oil Tonic

    ODSP Director Cara Welch Discusses Agency Priorities

    Alkemist Labs Warns About Missing Components to Pesticide Testing
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Boswellia and Bengal Quince Fruit Extract Blend Linked to Respiratory Benefits

    Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products

    Lynside® Forte B offers full range of B-vitamin benefits with nutritional yeast

    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise

    Shiitake Mushroom Extract Appears Helpful in HPV Infections
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Gencor

    JRS Pharma

    Nutrition21, LLC

    Ecuadorian Rainforest

    Xsto Solutions
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Gencor

    JRS Pharma

    Nutrition21, LLC

    Ecuadorian Rainforest

    Xsto Solutions
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Hemp Industry Experts Call for Unity in Turbulent Years to Come

    Murky regulatory status, competition from synthetic analogues, a global pandemic, and politics will present challenges to the hemp industry.

    Hemp Industry Experts Call for Unity in Turbulent Years to Come
    Related CONTENT
    • Largest Cannabinoids Trial to Date Yields Positive Findings on Pain Management
    • CHPA Hires Two Key Personnel
    • Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose
    • Kemin Launches Luxiva Hemp CBD Distillates
    • EFSA: Data Too Limited To Evaluate CBD as Novel Food Ingredient
    By Mike Montemarano, Associate Editor05.26.20
    At the Hemp Collective Summit, which took place virtually this year due to the COVID-19 pandemic, two industry leaders discussed the most beneficial ways in which the industries behind cannabidiol (CBD) and other hemp-derived products should brace themselves for a murky, high-stakes regulatory future.
     
    Since the enactment of the federal 2018 Farm Bill, legislation which allowed hemp farmers to grow and sell hemp-derived materials containing less than 0.3% THC, a patchwork of regulatory matters pertinent to hemp products have been enforced at different levels of discretion by all 50 U.S. states. Investor enthusiasm, consumer demand, and product launches exploded, peaking in 2019.
     
    John Grubb, managing partner at Summit Venture Management, described the hemp/CBD marketplace as adhering to “dog years,” in that the pace of the market dynamics in this arena move about seven times as quickly as those in any other segment of the dietary supplements industry.
     
    In spite of all this, there exists what Grubb described as a “broken link” in the regulatory structure surrounding CBD and hemp products at the federal level. While the 2018 Farm Bill, by all intents and purposes, was supportive by design of these products’ eventual path to market, no federal regulations exist to allow CBD or other hemp extracts to be sold directly as ingestibles (foods, beverages, or dietary supplements), greatly confounding the entire marketplace and consumers clamoring for extracts of the cannabis plant.
     
    “The FDA in its latest report wrote in a tone that left the market unsettled,” said United Natural Products Alliance (UNPA) President Loren Israelsen. He projected that a clear regulatory pathway for CBD supplements and other products to get to market may be as many as two to three years away. “The Farm Bill clearly shows intention to allow the lawful production of hemp to help farmers create a meaningful consumer products base for hemp. Where will these hemp products go if 75% of hemp production is tied into making CBD?”
     
    “The oxygen supply of this industry is diminishing,” Grubb said, after pointing to a number of severe valuation declines and spending cuts experienced by both small CBD businesses and also companies with the greatest amount of seed money and initial investment, largely brought on by the sheer regulatory risk involved in making advances in CBD products. Those getting in at the ground floor are facing a “tremendous amount of downward pressure,” Grubb added.
     
    Not every company that has put investments into CBD on the ground floor will weather the storm created by the uncertainty of the 2018 Farm Bill, but amid an estimated 1,500 to 3,500 brands that do, even the moderate projections for future CBD CAGRs are massive.

    Nonetheless, to see the industry dwindle down in competition would be a “tragedy,” Israelsen said. Further amplifying the difficulty in sustaining business is the COVID-19 pandemic. “COVID-induced sobriety is exacerbating retail challenges and smothering legislative priorities,” Grubb said. “There have been no meetings on The Hill despite many representatives showing sympathy to the industry for the broken link between the Farm Bill and the legalization of ingestible CBD.”
     
    Israelsen believes that, now more than ever, key players and investors in the CBD industry must present a unified front to federal regulators in pursuit of non-dietary ingredient acceptance for full-spectrum and broad spectrum hemp extracts, as well as CBD in dietary supplements, which will likely be the best shot for a clear, legal status on hemp extracts.
     
    NDI Likely to Trump GRAS
    “DSHEA (the Dietary Supplement Health and Education Act of 1994) provides a clear regulatory pathway to allow a substance that is approved as a drug to also be used as a dietary ingredient,” Israelsen said. CBD, as a molecule, has been patented as a drug called Epidiolex, which is used to treat seizures in children with rare, life-threatening disorders. “DSHEA never anticipated that one of these ingredients would be a controlled substance eventually released, which means that we would either need permission by FDA to submit these applications, or request that Congress directs the FDA to receive these NDI applications.”
     
    NDI status seems more achievable for CBD than the alternative GRAS (Generally Recognized As Safe) FDA status, due to the fact that NDIs require manufacturers to abide by maximum dosages made apparent to consumers. FDA will likely be much more resistant to offering CBD a GRAS status due to a number of trials indicating that the substance can cause liver damage in clinical settings, and due to the fact that so little is known about the long-term usage of CBD in high quantities. Dietary supplements are much more likely to be an approved format for CBD delivery than foods, which require all ingredients to have a GRAS status.
     
    “An NDI allows for a maximum, discrete dosage form,” Israelsen said. “It allows for cautionary language and explicit dosing language, and that can’t be done with food products. Foods have to be considered safe in any quantity, and FDA is concerned that a GRAS approach won’t take in the safety considerations involved with foods and beverages oversaturating the amount of allowable CBD and hemp extract constituents.”
     
    Widening the Spectrum
    Additionally, Israelsen said there is a broadening school of thought supporting the pursuit of approval for full- and broad-spectrum hemp extract as opposed to CBD, due to the fact that pharmaceutical companies are attempting to achieve patents on molecular isolates from hemp, and that there is a burgeoning development of synthetic CBD analogues which could achieve patent status through the benefits they provide. Already, isolates of the phytocannabinoids THCB and CBG are being studied for potential health benefits.
     
    “I think the wise choice is to recognize our situation, and leaders must recognize the collective benefits that naturally-derived hemp extract provides. We need order and harmony within this marketplace to police ourselves,” Israelsen said. “Some companies might naturally want to go alone, because the first company to get an NDI might be king of the mountain, and the advantage would be exceptional. I believe there will be multiple winners or no winners; no one individually will be able to convince FDA to give them what I believe will be the most difficult NDI to make.”
     
    Israelsen expressed doubts as to whether CBD could receive NDI designation at this point, now that it has been approved as a drug. For these reasons, he believes the best path forward is to pursue NDIs for full-spectrum hemp extracts, which contain over 120 cannabinoids excluding THC believed to be beneficial in many ways, along with flavonoids and terpenes which have known beneficial properties.
     
    “The FDA is reluctant to approve a dietary ingredient version of a recently-approved drug,” Israelsen said. “There is a broadening school of thought that hemp extract is the most appropriate subject of research, and can offer more product diversity.” Approaching NDI status for the whole plant provides a “richer pool of opportunity,” Israelsen said.
     
    With all of these stipulations in mind, synthetic hemp analogues are further challenging the long-term viability of an already-burdened fledgling market surrounding the herb that has been cultivated for thousands of years.
     
    “Companies are specializing in synthetic copies of cannabinoids,” Israelsen said. “They’ve organized themselves into a group that are also lobbying congress and FDA, and they’re seeking molecular neutrality between natural and synthetic, and are seeking out equal recognition with hemp benefits seen in the Farm Bill. They believe they can produce synthetics more cheaply than hemp-derived products, and have a competitive price advantage, and would like to move against pharmaceutical products to become generic producers.”

    Largely, it appears to most in the industry that synthetic alternatives would negate the incentives provided to hemp farmers, which were essentially the ends of the 2018 Farm Bill. Israelsen said members of Congress have been briefed on this issue, and that some seem intent to protect the naturally-derived hemp extract marketplace.
     
    “Congress will remember what they did in 2018 to help the farmer, and will recognize the existential threat that synthetic cannabinoids place on the industry,” Israelsen said.
     
    Whether any major moves in the political sphere will happen any time soon is another story, given how difficult it is for bills to pass at this time in large part due to the urgency in passing legislation related to COVID-19, and in part due to the politicking that will take place until November involving proponents of the 2018 Farm Bill, including Senate Majority Leader Mitch McConnell.
     
    “It’s exceptionally difficult to project any kind of timing due to COVID and Senator McConnell’s reelection campaign. There are greater electoral politics at play,” Israelsen said. “I believe that if Las Vegas was open right now they wouldn’t be taking bets on this. We have a short and treacherous pathway to protect the potential of this marketplace.”
    Related Searches
    • Dietary Supplements
    • World Markets
    • Quality & Safety
    • Herbs & Botanicals
    Related Knowledge Center
    • Herbs & Botanicals
    • Dietary Supplements
    • World Markets
    Suggested For You
    Largest Cannabinoids Trial to Date Yields Positive Findings on Pain Management Largest Cannabinoids Trial to Date Yields Positive Findings on Pain Management
    CHPA Hires Two Key Personnel CHPA Hires Two Key Personnel
    Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose
    Kemin Launches Luxiva Hemp CBD Distillates Kemin Launches Luxiva Hemp CBD Distillates
    EFSA: Data Too Limited To Evaluate CBD as Novel Food Ingredient EFSA: Data Too Limited To Evaluate CBD as Novel Food Ingredient
    Tapping Functional Beverages to Meet Modern Wellness Needs Tapping Functional Beverages to Meet Modern Wellness Needs
    What People Were Reading in May 2022 on NutraceuticalsWorld.com What People Were Reading in May 2022 on NutraceuticalsWorld.com
    FDA Issues Draft Guidance on NDI Enforcement Discretion FDA Issues Draft Guidance on NDI Enforcement Discretion
    Jordan Process Receives Nutrasource ICAP Certification for CBD Jordan Process Receives Nutrasource ICAP Certification for CBD
    Draft Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision Draft Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision
    Open Book Extracts Completes Phase 1 of Toxicology, Safety Assessment for Cannabinoid Ingredients Open Book Extracts Completes Phase 1 of Toxicology, Safety Assessment for Cannabinoid Ingredients
    FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products
    HP Ingredients and H&AD to Showcase Ingredients at Vitafoods Europe HP Ingredients and H&AD to Showcase Ingredients at Vitafoods Europe
    Environmental, Social and Governance in the Cannabis Industry: A Perfect Storm is Brewing Environmental, Social and Governance in the Cannabis Industry: A Perfect Storm is Brewing
    James Roza of Layn Natural Ingredients: Driving the Science and Botanical Innovation James Roza of Layn Natural Ingredients: Driving the Science and Botanical Innovation

    Related Breaking News

    • Breaking News | Herbs & Botanicals | Medical Nutrition | Research | Research News
      Largest Cannabinoids Trial to Date Yields Positive Findings on Pain Management

      Largest Cannabinoids Trial to Date Yields Positive Findings on Pain Management

      Over 1,600 people with pain were randomized to take one of six cannabinoid formulations containing CBD and some combination of rare cannabinoids from OBX.
      07.05.22

    • Breaking News | Dietary Supplements | People News
      CHPA Hires Two Key Personnel

      CHPA Hires Two Key Personnel

      Larisa Pavlick and Kirby Miller will each play strategic roles for the trade association on science-based policy, technical issues, and more.
      06.21.22

    • Dietary Supplements | Regulations
      Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose

      Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose

      Wide-ranging ‘must-pass’ legislation heads to the full Senate for consideration.
      By Mike Montemarano, Associate Editor 06.17.22


    • Breaking News | Herbs & Botanicals | Supplier News
      Kemin Launches Luxiva Hemp CBD Distillates

      Kemin Launches Luxiva Hemp CBD Distillates

      The ingredient supplier expanded its hemp portfolio with a line of organic distillates at varying potencies.
      06.15.22

    • Breaking News | Herbs & Botanicals | Quality & Safety | Regulatory News | Research | World Markets
      EFSA: Data Too Limited To Evaluate CBD as Novel Food Ingredient

      EFSA: Data Too Limited To Evaluate CBD as Novel Food Ingredient

      In a statement issued by Europe’s foremost food safety authority, several data gaps on the safety of CBD were noted.
      06.08.22

    Loading, Please Wait..
    Trending
    • High Blood DHA Levels Linked To 49% Reduced Risk Of Alzheimer’s
    • Three Grams Of Omega-3s May Be Optimal Dose For Reducing Blood Pressure
    • CoQ10 And Royal Jelly Supplementation May Improve High Intensity Exercise
    • Oregon Files Lawsuit Against GNC
    • First Day Life Shuts Down Children's Behavioral, Cognitive Health Claims Following Challenge
    Breaking News
    • CRN Announces New Staff Appointments
    • Food Supplements Europe: Most Consumers Use Dietary Supplements Safely
    • True Westfjords Launches Dropi Cod Liver Oil Tonic
    • Alkemist Labs Warns About Missing Components to Pesticide Testing
    • Boswellia and Bengal Quince Fruit Extract Blend Linked to Respiratory Benefits
    View Breaking News >
    CURRENT ISSUE

    June 2022

    • Tapping Functional Beverages to Meet Modern Wellness Needs
    • Adaptogens: Where Ancient Remedies Meet Modern Wellness Products
    • New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance
    • Health Products Association - China Executive Director Reflects on Market Dynamics, Challenges
    • Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    CRN Announces New Staff Appointments
    Food Supplements Europe: Most Consumers Use Dietary Supplements Safely
    True Westfjords Launches Dropi Cod Liver Oil Tonic
    Coatings World

    Latest Breaking News From Coatings World

    AkzoNobel to Acquire Lankwitzer Lackfabrik’s Aluminum Wheel Liquid Coatings Business
    Waterborne Symposium Issues 2023 Call for Papers
    JNS-SmithChem Acquires Gulf Coast Chemical in Tampa, Florida
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BD Appoints Rishi Grover as Chief Integrated Supply Chain Officer
    3M to Shed Neoplast, Neobun Brands
    FDA OKs Ra Medical Systems' DABRA 2.0 Catheter
    Contract Pharma

    Latest Breaking News From Contract Pharma

    TCG Lifesciences Inaugurates New R&D Facility in Pune
    Fujifilm Investing $1.6B to Expand Cell Culture Manufacturing Services
    Sharp Expands Clinical Services Operations at Heerenveen Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Arkay Receives Platinum Rating in EcoVadis CSR Assessment
    Kevyn Aucoin Beauty To Launch Contour Eyeshadow Palettes
    Junoco Promotes #ToBeHuman Campaign
    Happi

    Latest Breaking News From Happi

    Proven Skincare Awarded US Patent for Personalization Process
    Clorox and Gojo Join Responsible Flushing Alliance
    Sustainability Expert Aris Vrettos Joins Croda
    Ink World

    Latest Breaking News From Ink World

    BASF Venture Capital Invests in Climentum Capital’s First Fund
    JNS-SmithChem Acquires Tampa-Based Gulf Coast Chemical
    Quad Added to Membership of US Small-Cap Russell 2000 Index
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Optimum Group acquires Labelco
    Provident announces appointment of Jake Garner
    APR announces VP promotions
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Paper Excellence Group to Buy Resolute Forest Products
    Rose Baby Diaper Brand to Be Available in U.S.
    SWM, Neenah Complete Merger of Equals
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    No Revisions, Few Complications for Exactech's Total Ankle System
    SpineX Begins SCONE Clinical Trial
    First Patient Enrolled in BioRestorative Therapies' Chronic Lumbar Disc Disease Trial
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    NREL Scientists Explore How to Make PV Even Greener
    ams OSRAM Announces Closing of Sale of AMLS Business to Plastic Omnium
    Confidex’s Carrier Dual Delivers Shared RAIN RFID and NFC Memory

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login